Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by Spartrapon Jul 09, 2020 8:10pm
299 Views
Post# 31248863

Tesamorelin used by "age-management community"?

Tesamorelin used by "age-management community"?

Looks like some crazy people are willing to buy tesamorelin from dubious sources and inject it to themselves daily, expecting various benefits including cognitive on top of the fat-burning effect.

https://viorlife.com/tesamorelin-the-abdominal-fat-burning-peptide/

See the video in this page, it's incredible. The product comes in some shiny, silvery package, like it's some kind of innocuous vitamins.. I'm floored.

This makes me wonder what will happen after the patent cliff.

Some people were saying here IIRC that Egrifta being such a niche product, it wouldn't attract much interest from generic drugs makers. Well, it seems obvious that this thesis is flawed..

<< Previous
Bullboard Posts
Next >>